December 7, 2021 Research Bulletin

Featured Funding Opportunities

• 1/9/2022 - Pharmacokinetics (PD) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional)
• 1/25/2022 - Specialized Programs of Research Excellence (SPOREs) in Human Cancers
• 1/31/2022 - American Society of Hematology Minority Medical Student Award Program
• 2/18/2022 - Advancing Validated Drug Targets for Substance Use Disorders (R43/R44 - Clinical Trial Not Allowed)
• 3/1/2022 - Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
• 4/1/2022 - Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01 - Clinical Trial Not Allowed) National Artificial Intelligence (AI) Research Institutes Acccelerating Research, Transforming Society, and Growing the American Workforce
• 5/22/2022 - Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care
• 6/7/2022 - Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

NIH Funding Announcements

Limited Funding Opportunities

To submit a proposal for these opportunities:

Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format via the Limited Submission Portal.

Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences

• Materials due to Internal Review Committee: March 15, 2022
  
• Sponsor Due Date: June 24, 2022

NIH Science Education Partnership Award

• Materials due to Internal Review Committee: May 17, 2022
  
• Sponsor Due Date: July 13, 2022

NCI K99/R00 Funding Opportunity

The University of Colorado Denver has the opportunity to nominate up to 3 candidates for the NCI’s K99/R00 funding opportunity. One nomination is allowed in each of the following areas of research: 

(A) Data Science: an interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are both developed and used to extract knowledge and insights from increasingly large and/or complex sets of data. This includes cancer-focused data integration and visualization, systems biology, artificial intelligence, machine learning, informatics, genomics, precision oncology, and developing analytics for epidemiological or biostatistical studies. 

(B) Cancer Control Science: basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches, reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. This includes research in epidemiology, behavioral sciences, health services, surveillance, cancer survivorship, and healthcare policy. 

(C) Other Sciences: Includes all scientific fields supported by NCI that are not included in (A) or (B). Applicants proposing research in (C) "Other Sciences" may apply only if it is reasonable to expect them to transition to independence with an abbreviated period of mentored research training beyond their original doctoral degrees. Postdoctoral fellows in other areas of NCI-supported research who require additional postdoctoral training are encouraged to apply to the NIH Parent K99/R00 program (PA-20-187, PA-20-188, or PA-20-189). K99/R00 candidates must have no more than 2 years of postdoctoral research experience as of the application due date and must be in mentored, postdoctoral training positions.

The K99/R00 award is intended for individuals who require no more than 2 additional years of mentored research training and career development (K99 phase) before transitioning to the independent stage (R00 phase) of the program. Consequently, the strongest applicants will require, and will propose, a well-conceived plan for 1–2 years of substantive mentored research training and career development that will help them become competitive candidates for tenure-track faculty positions and prepare them to launch robust, independent research programs. 

Interested candidates must meet all eligibility criteria. 

Candidates are encouraged to contact Sergey Radaev, PhD in the NCI’s Training Branch to confirm eligibility before submitting to the internal nomination process. 

The NCI will hold a pre-application webinar on Tuesday, December 14, from 12-1pm MST.

• Meeting Access Code:  2315 876 9803
• Meeting Password:  Jz7iSKRK7*7
• Join from the meeting link
• Join by phone:  1-650-479-3207 Call-in toll number (US/Canada)

If you would like to be considered for this opportunity, please submit your information by Thursday, December 30 at 5pm. 

For additional questions, please contact Michaela Montour.

The Lorna Grindlay Moore, PhD Faculty Launch Fund

The CU Denver and CU Anschutz Medical Campus proudly announce the next call for applications for the Lorna Grindlay Moore, PhD, Faculty Launch Award. Eligible Instructors and Assistant Professors are invited to apply for a one-year award of $40,000 to help launch their independent research programs. Faculty may be appointed in any of the schools or colleges of the CU Denver or CU Anschutz campuses whose research is centered on women’s health during and after the reproductive period. Appropriate areas include, but are not limited to pregnancy, family planning, infertility, oncology, education, public policy, mental health, cardiovascular health, diabetes, advancing the academic careers of women faculty and the effect of COVID-19 on women’s health.

For more information visit the Department of Obstetrics and Gynecology website or RFA.

• Due date for Letter of Intent: January 21, 2022
• Due date for Applications: March 23, 2022
• Funds available as of July 1, 2022

Special Announcements

The University of Colorado T32 Training Grant (Integrative Physiology of Aging).   

Applications from Pre-doctoral and Post-doctoral candidates are being accepted.

• One year of support can be committed at this time
• There will be 1 Post-doctoral and 4 Pre-doctoral slots available

Applications are due Friday, January 28, 2022 at 4:00pm. 

All applicants must have their mentor contact Kerrie Moreau, PhD prior to applying.

SOM ASPIRE Program

We are pleased to announce a new RFA to foster the development of interdisciplinary, programmatic research on campus. The goal of the CU Anschutz SOM Programmatic Incubator for Research (CU ASPIRE) Program is to increase submission and success of program project, center grants, and large multi-investigator programs on campus by supporting milestone-driven collaborations between investigators across campus.

• Two awards will be made annually up to $100,000/year each for up to 2 years of support
• At least 3 and no more than 5 investigators are required as part of the application
• PI must hold a primary appointment in a Department within the School of Medicine.
• Due date: February 14, 2022

Questions should be directed to Jennifer Kemp or Bethany Ginzburg

This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.   

Past Research Bulletins can be found here.

Please click here if you wish to be added to this distribution.